S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Deep Track Capital/Q2 2024

Deep Track Capital

Periodo: Q2 2024 · Depositato: 2024-08-14
Vedi su SEC EDGAR
AUM
$3.35B
Valore totale del portafoglio
Posizioni
68
Titoli dichiarati
Prima Posizione
AMGN
5.4% $179.7M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2024-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
AMGNAMGEN INC$179.7M5.36%$292.50$374.15+27.9%
5.4%
ARGXARGENX SE$172.0M5.13%$434.22$939.68+116.4%
5.1%
AXSMAXSOME THERAPEUTICS INC$149.2M4.45%$81.03$244.31+201.5%
4.5%
DYNDYNE THERAPEUTICS INC$141.2M4.21%$35.49$23.07-35.0%
4.2%
SWTXSPRINGWORKS THERAPEUTICS INC$139.4M4.16%
4.2%
INSMINSMED INC$134.0M4.00%$66.34$111.60+68.2%
4.0%
GHGUARDANT HEALTH INC$130.0M3.88%$28.26$167.98+494.4%
3.9%
DVAXDYNAVAX TECHNOLOGIES CORP$122.4M3.65%
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$121.5M3.63%$243.32$312.78+28.6%
3.6%
NTLAINTELLIA THERAPEUTICS INC$107.4M3.21%$22.47$17.56-21.9%
3.2%
ITCIINTRA-CELLULAR THERAPIES INC$105.3M3.14%
3.1%
APLSAPELLIS PHARMACEUTICALS INC$95.9M2.86%$36.29
2.9%
IONSIONIS PHARMACEUTICALS INC$95.3M2.85%$47.11$81.80+73.6%
2.9%
OCULOCULAR THERAPEUTIX INC$87.0M2.60%$6.66$9.64+44.7%
2.6%
FDMT4D MOLECULAR THERAPEUTICS IN$85.3M2.54%$21.34$13.00-39.1%
2.5%
ALKSALKERMES PLC$84.3M2.52%$24.39$54.58+123.8%
2.5%
NRIXNURIX THERAPEUTICS INC$83.3M2.49%$20.91$23.97+14.6%
2.5%
IMVTIMMUNOVANT INC$76.1M2.27%$27.51$38.79+41.0%
2.3%
BCYCBICYCLE THERAPEUTICS PLC$70.7M2.11%$20.29$4.35-78.6%
2.1%
PLRXPLIANT THERAPEUTICS INC$64.2M1.92%$10.86$1.17-89.2%
1.9%
TVTXTRAVERE THERAPEUTICS INC$60.6M1.81%$8.28$56.92+587.4%
1.8%
VRNAVERONA PHARMA PLC$57.8M1.73%
1.7%
ABVXABIVAX SA$55.3M1.65%$13.56$144.65+966.7%
1.6%
GERNGERON CORP$55.1M1.65%$4.34$1.36-68.7%
1.6%
AUTLAUTOLUS THERAPEUTICS PLC$53.1M1.59%$3.47$1.58-54.5%
1.6%
TGTXTG THERAPEUTICS INC$51.1M1.52%$18.15$53.31+193.7%
1.5%
VRDNVIRIDIAN THERAPEUTICS INC$51.0M1.52%$13.21$19.40+46.9%
1.5%
KYMRKYMERA THERAPEUTICS INC$44.8M1.34%$30.95$113.51+266.8%
1.3%
MNMDMIND MEDICINE MINDMED INC$44.0M1.31%
1.3%
OLMAOLEMA PHARMACEUTICALS INC$43.3M1.29%$11.14$12.64+13.5%
1.3%

Attività Trimestre su Trimestre

Q2 2024 vs. Q1 2024

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
TGTXTG THERAPEUTICS INC$51.1M+193.7%
CLYMELIEM THERAPEUTICS INC$27.8M
KRROKORRO BIO INC$26.1M
ETNB89BIO INC$18.4M
INOINOVIO PHARMACEUTICALS INC$16.7M
PRAXPRAXIS PRECISION MEDICINES I$16.1M
CNTXCONTEXT THERAPEUTICS INC$14.9M
KURAKURA ONCOLOGY INC$7.9M

Posizioni Chiuse (8)

TickerEmittenteNozionale
TRMLTOURMALINE BIO INC$36.5M
PACBPACIFIC BIOSCIENCES CALIF IN$26.3M
NUVLNUVALENT INC$20.6M
AGENAGENUS INC$18.4M
ANABANAPTYSBIO INC$11.9M
RAREULTRAGENYX PHARMACEUTICAL IN$7.8M
MRSNMERSANA THERAPEUTICS INC$2.6M
PRMEPRIME MEDICINE INC$2.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
GPCRSTRUCTURE THERAPEUTICS INC$35.6M+2266.9%
ITCIINTRA-CELLULAR THERAPIES INC$93.2M+776.8%
IMVTIMMUNOVANT INC$60.2M+484.5%+41.0%
APLSAPELLIS PHARMACEUTICALS INC$37.1M+150.0%
IONSIONIS PHARMACEUTICALS INC$35.8M+45.6%+73.6%
SYRESPYRE THERAPEUTICS INC$-4.7M+44.8%
AXSMAXSOME THERAPEUTICS INC$45.0M+42.0%+201.5%
FDMT4D MOLECULAR THERAPEUTICS IN$-11.4M+33.8%-39.1%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NMRACALLNEUMORA THERAPEUTICS INC.$-12.0M-82.0%
RPTXREPARE THERAPEUTICS INC$-9.7M-66.3%
VIGLVIGIL NEUROSCIENCE INC$-3.0M-62.6%
INSMINSMED INC$4.2M-58.2%+68.2%
GERNGERON CORP$-45.5M-57.4%-68.7%
APGEAPOGEE THERAPEUTICS INC$-115.0M-57.0%
SRRKSCHOLAR ROCK HLDG CORP$-9.0M-45.2%
ANIPANI PHARMACEUTICALS INC$-27.1M-43.3%
Torna agli Hedge Fund